Portfolio Alerts Watch List Cart

SBI Healthcare Opp Fund(IDCW-Payout)

Ticker: mf15108
Decent 68/100

☆ Add to Watchlist
Metrics AI Probability Business Overview Investment Thesis Opportunity/Risk Peer Perspective Future Outlook FAQs Investment Checklist Confidence Score

More Options

S
SBI Healthcare Opp Fund(IDCW)
Score 66/100 Decent
The fund shows potential in the healthcare sector but has several risks that need to be monitored closely.
View details
H
Helios Flexi Cap Fund(IDCW)
Score 68/100 Decent
The Helios Flexi Cap Fund shows decent potential with a balanced approach to growth and profitability, but investors should remain cautious of execution risks.
View details
H
Helios Flexi Cap Fund(IDCW Payout)
Score 68/100 Decent
The Helios Flexi Cap Fund shows decent potential with consistent growth and profitability metrics, but some risks in execution and market sentiment should be monitored.
View details
H
HDFC Medium Term Debt Fund(FN-IDCW Reinv)
Score 70/100 Decent
The HDFC Medium Term Debt Fund shows decent potential but faces several challenges that could impact future performance.
View details
H
HDFC Medium Term Debt Fund(IDCW-Reinv)
Score 48/100 Decent
The fund shows decent stability but lacks strong growth catalysts, making it a cautious investment.
View details
H
HDFC Medium Term Debt Fund(IDCW)
Score 68/100 Decent
The fund shows decent potential but is hindered by inconsistent growth and market sentiment.
View details
H
HDFC Medium Term Debt Fund(FN-IDCW)
Score 48/100 Decent
The fund shows moderate potential but carries several risks that could impact performance.
View details
M
Mahindra Manulife Mid Cap Fund(IDCW-Payout)
Score 68/100 Decent
The Mahindra Manulife Mid Cap Fund shows decent potential for growth with a balanced approach to risk and returns.
View details
M
Mahindra Manulife Mid Cap Fund(IDCW)
Score 68/100 Decent
The fund shows potential in the mid-cap space but faces challenges in growth consistency and valuation metrics.
View details
N
Nippon India Aggressive Hybrid Fund(M-IDCW)
Score 48/100 Decent
The fund shows decent potential with a balanced approach, but investors should be cautious of valuation and execution risks.
View details
N
Nippon India Aggressive Hybrid Fund(Q-IDCW)
Score 68/100 Decent
The Nippon India Aggressive Hybrid Fund shows decent potential for growth with manageable risks, making it a reasonable investment option.
View details
N
Nippon India Aggressive Hybrid Fund(IDCW)
Score 66/100 Decent
The Nippon India Aggressive Hybrid Fund shows decent potential with a balanced approach to growth and profitability, though some risks and governance concerns exist.
View details
N
NJ Balanced Advantage Fund(IDCW)
Score 68/100 Decent
The NJ Balanced Advantage Fund shows decent potential with a stable growth outlook, but investors should be cautious of execution risks and valuation metrics.
View details
F
Franklin India Money Market Fund(M-IDCW)
Score 48/100 Decent
The fund shows decent potential for returns but comes with moderate risks. Investors should consider their risk appetite before investing.
View details
F
Franklin India Money Market Fund(DD-IDCW)
Score 48/100 Decent
The fund shows decent fundamentals but lacks strong growth drivers and technical momentum.
View details
F
Franklin India Money Market Fund(Q-IDCW)
Score 70/100 Decent
The fund shows decent potential with stable performance, but investors should be cautious of limited growth drivers and execution risks.
View details

Business Overview

The SBI Healthcare Opportunities Fund (IDCW-Payout) is a specialized mutual fund designed to capitalize on growth in the healthcare sector. Ideal for investors seeking long-term wealth creation through exposure to healthcare stocks, this fund focuses on companies involved in pharmaceuticals, biotechnology, and healthcare services. With a robust investment strategy, it aims to deliver attractive returns while managing risk. This fund is perfect for those looking to diversify their portfolio with a focus on a resilient sector that benefits from increasing healthcare demands.

  • Focuses on high-growth healthcare sector
  • Ideal for long-term wealth creation
  • Invests in pharmaceuticals and biotech
  • Offers regular income through IDCW
  • Managed by experienced professionals
  • Diversifies investment portfolio effectively

Investment Thesis

SBI Healthcare Opp Fund stands out due to its strong backing from the SBI Group, ensuring credibility and stability. The fund is well-positioned to capitalize on the burgeoning digital healthcare services market. Additionally, its attractive valuation compared to peers presents a compelling investment opportunity for retail investors seeking growth in the healthcare sector.

  • Strong promoter group: Backed by SBI, a trusted name in financial services.
  • Significant growth potential in digital healthcare services.
  • Attractive valuation compared to industry peers, enhancing investment appeal.
  • Focus on healthcare sector aligns with increasing consumer demand.
  • Robust management strategies aimed at maximizing returns.
📊 Stock Investment Checklist (100 Points)
SBI Healthcare Opp Fund(IDCW-Payout) • Updated: 2025-10-01 07:10:31
  • 10
    Business
    High
    Healthcare sector is growing but faces regulatory challenges.
  • 10
    Growth
    High
    Consistent revenue growth observed, but profit margins are fluctuating.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF is inconsistent.
  • 8
    Valuation
    High
    Valuation metrics are slightly above peers.
  • 7
    Balance
    High
    Moderate debt levels, liquidity is acceptable.
  • 6
    Governance
    Good
    Promoter holding is stable, but some pledging exists.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks are notable.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100 • Decent
The fund shows potential in the healthcare sector with decent growth prospects, but faces challenges in profitability and execution risks.